Adults 18 to 50, female only, with Health Attitude or Knowledge, Attitudes, Practice. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Reporting Being Satisfied or Very Satisfied About Their Overall Intervention ExperiencePrimary· 6 months
Number of participants reporting being "satisfied" or "very satisfied" with their overall intervention experience, assessed through a five-point Likert scale at six months.
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
90
Arm 2: Asynchronous Support
19
Number of Participants Engaging in Group Call InterventionPrimary· 6 months
Number of participants who engaged in weekly group call intervention activities by 6 months
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
37
Number of Participants With Knowledge on Maternal and Neonatal Danger Signs, Best Practices for Infant Care, Family Planning.Secondary· 6 months
Number of participants correctly identifying at least 80% of knowledge on maternal and neonatal danger signs, best practices for infant care, and family planning at 6 months.
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
0
Arm 2: Asynchronous Support
0
Arm 3: Control
0
Number of Participants Exclusively BreastfeedingSecondary· 6 months
Number of participants who exclusively breastfed their infants through 6 months of age
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
79
Arm 2: Asynchronous Support
18
Arm 3: Control
11
Number of Participants Reporting Postpartum DepressionSecondary· 6 months
Number of participants reporting postpartum depression symptoms at six months
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
43
Arm 2: Asynchronous Support
10
Arm 3: Control
5
Number of Participants Who Adopted Postpartum Family PlanningSecondary· 6 months
Number of participants who started a modern contraceptive methods within 6 months postpartum
Group
Value
95% CI
Arm 1: Synchronous and Asynchronous Support
67
Arm 2: Asynchronous Support
14
Arm 3: Control
10
Sponsor's own description
The goal of the study is to assess the feasibility and acceptability of the optimized MeSSSSage intervention which was developed and revised based on the results of our initial pilot testing. The investigators will conduct a controlled 4-arm factorial design randomized study to test the feasibility, acceptability and preliminary effectiveness of several intervention modalities over a 6-month period.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06081452 — Public Survey on Breath Testing for Health and Disease
· recruiting
NCT03592563 — CUHK Brain Health Longitudinal Study
· recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
NCT05284773 — Screening for Acute Malnutrition
· NA
· withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling
· NA
· not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M
· Phase 1, PHASE2
· not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans
· NA
· not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT)
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 12 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04693585.